These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21238657

  • 1. Elements of successful intestinal rehabilitation.
    Sigalet D, Boctor D, Brindle M, Lam V, Robertson M.
    J Pediatr Surg; 2011 Jan; 46(1):150-6. PubMed ID: 21238657
    [Abstract] [Full Text] [Related]

  • 2. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.
    Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, Driedger L, Sajedi M.
    Eur J Pediatr Surg; 2009 Dec; 19(6):348-53. PubMed ID: 19866409
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [Abstract] [Full Text] [Related]

  • 4. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [Abstract] [Full Text] [Related]

  • 5. Some new insights in intestinal failure-associated liver disease.
    Goulet O, Joly F, Corriol O, Colomb-Jung V.
    Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
    [Abstract] [Full Text] [Related]

  • 6. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT, Nespor C, Kerner J.
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [Abstract] [Full Text] [Related]

  • 7. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
    Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M.
    Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
    [Abstract] [Full Text] [Related]

  • 8. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury.
    Arsenault DA, Potemkin AK, Robinson EM, Fallon EM, Ozonoff A, de Meijer VE, Puder M.
    J Pediatr Surg; 2011 Jan; 46(1):122-7. PubMed ID: 21238652
    [Abstract] [Full Text] [Related]

  • 9. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [Abstract] [Full Text] [Related]

  • 10. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions.
    Lilja HE, Finkel Y, Paulsson M, Lucas S.
    J Pediatr Surg; 2011 Jul; 46(7):1361-7. PubMed ID: 21763835
    [Abstract] [Full Text] [Related]

  • 11. Preventing parenteral nutrition liver disease.
    Kelly DA.
    Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
    [Abstract] [Full Text] [Related]

  • 12. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [Abstract] [Full Text] [Related]

  • 13. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, Carroll J, Jan DM.
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [Abstract] [Full Text] [Related]

  • 14. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [Abstract] [Full Text] [Related]

  • 15. An exclusively based parenteral fish-oil emulsion reverses cholestasis.
    Triana Junco M, García Vázquez N, Zozaya C, Ybarra Zabala M, Abrams S, García de Lorenzo A, Sáenz de Pipaón Marcos M.
    Nutr Hosp; 2014 Oct 25; 31(1):514-6. PubMed ID: 25561149
    [Abstract] [Full Text] [Related]

  • 16. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
    Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC.
    Clin Nutr; 2009 Apr 25; 28(2):209-12. PubMed ID: 19261360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study.
    Pawlik D, Lauterbach R, Walczak M, Hurkała J, Sherman MP.
    JPEN J Parenter Enteral Nutr; 2014 Aug 25; 38(6):711-6. PubMed ID: 23963690
    [Abstract] [Full Text] [Related]

  • 19. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM.
    Ann Surg; 2009 Sep 25; 250(3):395-402. PubMed ID: 19661785
    [Abstract] [Full Text] [Related]

  • 20. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM, Le HD, Puder M.
    Curr Opin Organ Transplant; 2010 Jun 25; 15(3):334-40. PubMed ID: 20503524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.